Drug Modalities
Technical Solutions
ESG
Newsroom
About Us
CN
Home/Newsroom/News

News 2014-11-03

The general manager attended the CHPI in Paris.

The general manager of Porton, Andrew Xu, together with partial members from BD team, R&D team and Project Management team attended the CHPI which was held in Paris from Oct. 7th to 9th, 2014.

Others
More

News 2026-03-31

Porton Newsletter - March 2026 Recap

Porton Newsletter - March 2026 Recap
peptide CDMO

News 2026-03-22

Porton and Jianxiang Forge Strategic Partnership to Build a New High Ground for Large-scale Peptide Drug Manufacturing

Porton and Jianxiang partner to deliver integrated peptide CDMO services from development to commercial manufacturing, offering scalable, compliant solutions for global clients.
Become part of Porton's community to access personalized insights and resources.
Subscribe for the Newsletter
Porton requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and our commitment to protecting your privacy, please review our Legal Disclaimer Terms and Porton Privacy.
US: (609) 860-1300
CN: (86) 23-8608-3200

ⓒ 2025 PORTON Legal Notices | Porton Privacy

This website provides information on products tailored for a diverse audience and may include product details or information that are not readily accessible or valid in your country. Please note that we do not accept any responsibility for accessing such information in a manner that may violate any legal processes, regulations, registrations, or usage guidelines in your country of origin.

Become part of Porton's community to access personalized insights and resources.
Submit
By clicking “Submit” you agree to our Legal Disclaimer terms and conditions and the Porton Privacy and Cookies Policy.

ⓒ 2025 PORTON Legal Notices | Porton Privacy

US: (609) 860-1300
CN: (86) 23-8608-3200